Postbiotic Peptides Gain Spotlight in Gut‑Skin Axis Research
While most research remains preclinical, several startups have already filed patents around postbiotic peptide compositions. YUANDA has expressed interest in exploring this emerging category as a potential complement to its existing peptide portfolio.
Postbiotic Peptides Gain Spotlight in Gut‑Skin Axis Research
Global – A new class of bioactive molecules – postbiotic peptides – is drawing attention from both metabolic and dermatological researchers. These small protein fragments are produced by probiotic bacteria during fermentation and have been shown to modulate immune responses and barrier function in intestinal and skin models.
Recent findings presented at a European dermatology conference indicated that oral administration of specific postbiotic peptides reduced acne‑like lesions in an animal model, while also improving markers of systemic inflammation. The dual benefit aligns with the growing interest in holistic approaches to weight management and skin health.
While most research remains preclinical, several startups have already filed patents around postbiotic peptide compositions. YUANDA has expressed interest in exploring this emerging category as a potential complement to its existing peptide portfolio.